KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021)

Historic Change in Receivables for Recursion Pharmaceuticals (RXRX) over the last 2 years, with Q3 2021 value amounting to -$16000.0.

  • Recursion Pharmaceuticals' Change in Receivables fell 10005.3% to -$16000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was -$114000.0, marking a year-over-year decrease of 238000.0%. This contributed to the annual value of -$114000.0 for FY2021, which is 238000.0% down from last year.
  • Recursion Pharmaceuticals' Change in Receivables amounted to -$16000.0 in Q3 2021, which was down 10005.3% from -$13000.0 recorded in Q2 2021.
  • Over the past 5 years, Recursion Pharmaceuticals' Change in Receivables peaked at $30.2 million during Q3 2020, and registered a low of -$30.0 million during Q4 2020.